Skip to content

DIADEMA PARTNERS LP

Follow

13F filer, CIK 2026172, MORRISTOWN, NJ

DIADEMA PARTNERS LP reported $580,539,432 across 145 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 51.15% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001892688-26-000036

Period
2025-12-31
Reported value
$581M
Holdings
145
Top 10 weight
51.15%
New
71
Sold out
56

Largest buys vs the previous quarter

SecurityShares changeApprox. value
JNJnew+66,444$13.8M
BBIOnew+70,000$5.35M
VKTXadded+143,160$5.04M
UTHRnew+10,000$4.87M
ABVXadded+34,024$4.59M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
REGNreduced-19,860-$15.3M
PCVXreduced-195,313-$9.01M
INDIVIOR PLCreduced-236,932-$8.5M
SLNOreduced-150,438-$6.97M
BMYexited-130,000-$5.86M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001892688-26-000036, largest first. % of portfolio is the value over $167,913,829, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,370 shares; 2025Q1: 56,098 shares; 2025Q2: 259,852 shares; 2025Q3: 323,159 shares; 2025Q4: 345,880 shares 345,880$14M8.32%+22,721Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 66,444 shares 66,444$13.8M8.19%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 104,121 shares; 2025Q2: 197,468 shares; 2025Q3: 193,689 shares; 2025Q4: 336,849 shares 336,849$11.9M7.06%+143,160Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,620 shares; 2025Q4: 75,644 shares 75,644$10.2M6.08%+34,024Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 52,877 shares; 2025Q2: 192,877 shares; 2025Q3: 212,877 shares; 2025Q4: 146,361 shares 146,361$8.7M5.18%-66,516Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 29,828 shares; 2025Q2: 5,607 shares; 2025Q3: 30,160 shares; 2025Q4: 10,300 shares 10,300$7.95M4.73%-19,860Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares 70,000$5.35M3.19%newTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,000 shares 10,000$4.87M2.9%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 90,000 shares; 2025Q1: 392,213 shares; 2025Q2: 392,213 shares; 2025Q3: 97,813 shares; 2025Q4: 131,852 shares 131,852$4.68M2.79%+34,039Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 158,075 shares 158,075$4.56M2.72%newTimeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 10,000 shares 10,000$4.53M2.7%newTimeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 31,400 shares; 2025Q4: 53,354 shares 53,354$4.21M2.51%+21,954Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 47,805 shares; 2025Q1: 207,883 shares; 2025Q2: 371,448 shares; 2025Q3: 60,748 shares; 2025Q4: 123,283 shares 123,283$3.68M2.19%+62,535Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 271,164 shares 271,164$3.59M2.14%newTimeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 97,445 shares 97,445$3.39M2.02%newTimeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 243,170 shares 243,170$2.96M1.77%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 79,079 shares; 2025Q3: 59,079 shares; 2025Q4: 37,020 shares 37,020$2.95M1.76%-22,059Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 96,984 shares; 2025Q2: 104,384 shares; 2025Q3: 124,384 shares; 2025Q4: 70,300 shares 70,300$2.44M1.45%-54,084Timeline
IRWDIRONWOOD PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 683,611 shares 683,611$2.3M1.37%newTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 131,862 shares; 2025Q1: 164,048 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 90,000 shares 90,000$2.25M1.34%newTimeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 114,000 shares; 2025Q1: 74,530 shares; 2025Q2: 32,483 shares; 2025Q3: not reported; 2025Q4: 230,997 shares 230,997$2.25M1.34%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 19,302 shares; 2025Q2: 14,816 shares; 2025Q3: not reported; 2025Q4: 2,000 shares 2,000$2.15M1.28%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 13,115 shares; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 5,341 shares 5,341$2.12M1.26%-4,659Timeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 260,939 shares 260,939$2.1M1.25%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 76,185 shares; 2025Q3: 51,185 shares; 2025Q4: 22,700 shares 22,700$1.98M1.18%-28,485Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 389,395 shares 389,395$1.88M1.12%newTimeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 71,204 shares; 2025Q4: 200,000 shares 200,000$1.81M1.08%+128,796Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 350,000 shares 350,000$1.76M1.05%newTimeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 212,475 shares; 2025Q4: 302,000 shares 302,000$1.71M1.02%+89,525Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 334,251 shares 334,251$1.55M0.93%newTimeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 190,928 shares 190,928$1.49M0.89%newTimeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 252,198 shares 252,198$1.47M0.88%-147,802Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 25,276 shares; 2025Q1: 8,321 shares; 2025Q2: not reported; 2025Q3: 27,572 shares; 2025Q4: 6,840 shares 6,840$1.46M0.87%-20,732Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 74,753 shares; 2025Q4: 170,568 shares 170,568$1.34M0.8%+95,815Timeline
RIGLRIGEL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares 30,000$1.28M0.77%newTimeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 71,988 shares; 2025Q1: 93,002 shares; 2025Q2: 284,152 shares; 2025Q3: 177,330 shares; 2025Q4: 26,892 shares 26,892$1.25M0.74%-150,438Timeline
PCRXPACIRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 38,926 shares; 2025Q2: 58,926 shares; 2025Q3: 58,926 shares; 2025Q4: 48,025 shares 48,025$1.24M0.74%-10,901Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 180,000 shares; 2025Q2: 185,830 shares; 2025Q3: 85,830 shares; 2025Q4: 97,184 shares 97,184$1.22M0.72%+11,354Timeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 63,791 shares 63,791$1.12M0.67%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 36,500 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,000 shares 45,000$1.08M0.64%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 10,000 shares; 2025Q1: 92,385 shares; 2025Q2: 198,285 shares; 2025Q3: 218,285 shares; 2025Q4: 22,972 shares 22,972$1.06M0.63%-195,313Timeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 65,138 shares 65,138$1.03M0.61%newTimeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,539 shares 106,539$1.02M0.61%newTimeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 62,281 shares 62,281$977K0.58%newTimeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,320 shares 100,320$941K0.56%newTimeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 533,682 shares 533,682$929K0.55%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,000 shares 25,000$907K0.54%newTimeline
AYTUAYTU BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 272,670 shares; 2025Q4: 305,788 shares 305,788$795K0.47%+33,118Timeline
PTHSPELTHOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,498 shares; 2025Q4: 25,000 shares 25,000$775K0.46%+14,502Timeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,881 shares 21,881$755K0.45%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 1,359 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares 30,000$744K0.44%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 49,478 shares; 2025Q1: 162,063 shares; 2025Q2: 122,061 shares; 2025Q3: not reported; 2025Q4: 21,114 shares 21,114$657K0.39%newTimeline
INDIVIOR PLCINDIVIOR PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 254,252 shares; 2025Q4: 17,320 shares 17,320$621K0.37%-236,932
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares 100,000$603K0.36%newTimeline
LGNDLIGAND PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,987 shares 2,987$565K0.34%newTimeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,500 shares 20,500$557K0.33%newTimeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,181 shares 17,181$545K0.32%newTimeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 347,393 shares 347,393$538K0.32%+47,393Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,000 shares; 2025Q1: 76,220 shares; 2025Q2: 150,000 shares; 2025Q3: 90,000 shares; 2025Q4: 21,810 shares 21,810$511K0.3%-68,190Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 22,500 shares 22,500$483K0.29%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 166,049 shares 166,049$390K0.23%newTimeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 158,023 shares; 2025Q1: 207,694 shares; 2025Q2: 157,694 shares; 2025Q3: 157,694 shares; 2025Q4: 167,532 shares 167,532$338K0.2%+9,838Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 7,500 shares 7,500$281K0.17%-42,500Timeline
AARDAARDVARK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 15,882 shares 15,882$208K0.12%newTimeline
NEUPNEUPHORIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 21,452 shares; 2025Q4: 50,000 shares 50,000$194K0.12%+28,548Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 144,914 shares 144,914$177K0.11%newTimeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 30,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,500 shares 7,500$173K0.1%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 30,630 shares 30,630$165K0.1%-19,370Timeline
TLPHTALPHERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 136,923 shares 136,923$156K0.09%newTimeline
PRTCYPURETECH HEALTH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,324 shares; 2025Q3: 7,324 shares; 2025Q4: 7,442 shares 7,442$124K0.07%+118Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,299 shares 1,299$103K0.06%newTimeline
EDSAEDESA BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 54,025 shares 54,025$76.7K0.05%newTimeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 442,520 shares; 2025Q1: 565,975 shares; 2025Q2: 403,922 shares; 2025Q3: 349,789 shares; 2025Q4: 100,000 shares 100,000$66.2K0.04%-249,789Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
VRTXVERTEX PHARMACEUTICALS INC COMcall88,300$40Mnew
XBISPDR SERIES TRUST S&P BIOTECHput250,000$30.5Mnew
PRAXPRAXIS PRECISION MEDICINES I COM NEWput100,600$29.7M+600
VKTXVIKING THERAPEUTICS INC COMcall688,900$24.2M+283,800
RNAMAVIDITY BIOSCIENCES INC Stockcall328,000$23.7M+127,900
QQQINVESCO QQQ TR COMput30,000$18.4Mnew
JAZZJAZZ PHARMACEUTICALS PLC Stockcall105,300$17.9M+5,300
APGEAPOGEE THERAPEUTICS INC Stockcall211,100$15.9M+83,700
BBIOBRIDGEBIO PHARMA INC COMput200,000$15.3Mnew
GPCRSTRUCTURE THERAPEUTICS INC EQUITYcall191,700$13.3Mnew
VKTXVIKING THERAPEUTICS INC COMput316,700$11.1Mnew
BBIOBRIDGEBIO PHARMA INC COMcall139,600$10.7M+8,200
JNJJOHNSON & JOHNSON COMcall50,000$10.3Mnew
INCYINCYTE CORP Stockput100,000$9.88Mnew
INSMINSMED INC Stockcall52,800$9.19Mnew
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKcall312,300$9.01M+12,300
IONSIONIS PHARMACEUTICALS INC Stockcall106,200$8.4M+6,200
INDIVIOR PLCINDIVIOR PLC Common Stockcall220,300$7.9Mnew
QUREUNIQURE NV SHSput301,800$7.22M+1,800
ROIVROIVANT SCIENCES LTD SHSput318,700$6.92M+18,700
OCULOCULAR THERAPEUTIX INC COMcall545,200$6.62M+408,500
ZYMEZYMEWORKS INC COMcall240,600$6.33M+44,100
CRSPCRISPR THERAPEUTICS AG Stockcall112,700$5.91M+700
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKput200,000$5.77Mnew
CORTCORCEPT THERAPEUTICS INC COMput134,800$4.69M+108,300
REGNREGENERON PHARMACEUTICALS Stockcall5,000$3.86Mnew
MNKDMANNKIND CORP Stockcall552,300$3.13M-487,200
RXRXRECURSION PHARMACEUTICALS IN CL Acall741,900$3.03M+43,500
TGTXTG THERAPEUTICS INC Stockput100,000$2.98Mnew
NTLAINTELLIA THERAPEUTICS INC COMput316,900$2.85Mnew
GOSSGOSSAMER BIO INC Stockcall877,100$2.72M+52,300
NVONOVO-NORDISK A S ADRput53,100$2.7M-46,900
ABUSARBUTUS BIOPHARMA CORP Common Shares, without par valuecall548,600$2.64M+32,300
TERNTERNS PHARMACEUTICALS INC Stockcall64,700$2.61M-160,500
SLNOSOLENO THERAPEUTICS INC COMcall53,100$2.46M+3,100
OLMAOLEMA PHARMACEUTICALS INC COMcall96,100$2.4M+5,600
RAREULTRAGENYX PHARMACEUTICAL IN COMcall100,000$2.3M-50,000
BHVNBIOHAVEN LTD COMcall200,000$2.26Mnew
AQSTAQUESTIVE THERAPEUTICS INC Stockput337,700$2.18Mnew
TECXTECTONIC THERAPEUTIC INC COMMON STOCKcall100,600$2.1M+600
TVTXTRAVERE THERAPEUTICS INC COMput50,300$1.92M+50,000
NTLAINTELLIA THERAPEUTICS INC COMcall212,400$1.91M-257,800
CRMDCORMEDIX INC Stockput159,000$1.85M+59,000
ALTALTIMMUNE INC COM NEWcall491,800$1.78M+28,800
VNDAVANDA PHARMACEUTICALS INC COMcall200,000$1.76Mnew
SLSSELLAS LIFE SCIENCES GROUP I COM NEWcall424,900$1.6M+24,900
ANNXANNEXON INC COMcall309,100$1.55Mnew
LEGNLEGEND BIOTECH CORP SPONSORED ADScall69,000$1.5Mnew
AQSTAQUESTIVE THERAPEUTICS INC Stockcall211,100$1.36Mnew
MREOMEREO BIOPHARMA GROUP PLC CMNcall1,999,500$833K+479,300
KODKODIAK SCIENCES INC COMcall29,600$828K+1,800
EOLSEVOLUS INC COMcall118,800$790Knew
EDITEDITAS MEDICINE INC COMcall318,700$653K+18,700
MLTXMOONLAKE IMMUNOTHERAPEUTICS Stockcall47,200$622K+21,100
ZYMEZYMEWORKS INC COMput21,400$563Knew
VIRVIR BIOTECHNOLOGY INC COMcall89,200$538Knew
CNTACENTESSA PHARMACEUTICALS PLC SPONSORED ADScall21,100$528Knew
AVXLANAVEX LIFE SCIENCES CORP COM NEWcall140,600$501K+800
BDTXBLACK DIAMOND THERAPEUTICS I COMcall190,400$463Knew
JANXJANUX THERAPEUTICS INC COMcall30,000$414Knew
CRVSCORVUS PHARMACEUTICALS INC COMput53,100$409K+3,100
BIOABIOAGE LABS INC Stockcall22,600$299Knew
PBYIPUMA BIOTECHNOLOGY INC COMMON STOCKcall33,800$201K-102,100
INOINOVIO PHARMACEUTICALS INC COMMON STOCKcall100,000$174Knew
Reviva Pharmaceuticals Hold…Reviva Pharmaceuticals Holdings I… Common Stockcall500,000$140Knew
LYELLYELL IMMUNOPHARMA INC Stockput3,800$117Knew
VTGNVISTAGEN THERAPEUTICS INC COMcall106,500$70.5K+6,300
FLNAFILANA THERAPEUTICS INC CMNput10,600$21K+700
ATYRATYR PHARMA INC COM NEWcall15,500$12.1K-113,200
ATYRATYR PHARMA INC COM NEWput11,800$9.24K-64,400
JBIOJADE BIOSCIENCES INC COM NEWput1,046$2.97K0
Applied Therapeutics IncApplied Therapeutics Inc Common Stockcall20,200$2.02K+1,200

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SPYSTATE STR SPDR S&P 500 ETF T20,000$13.3Mput
AGIOAGIOS PHARMACEUTICALS INC222,100$8.92Mcall
INCYINCYTE CORP100,000$8.48Mcall
BMYBRISTOL-MYERS SQUIBB CO180,000$8.12Mcall
LLYELI LILLY & CO10,000$7.63Mput
SLNOSOLENO THERAPEUTICS INC100,000$6.76Mput
JAZZJAZZ PHARMACEUTICALS PLC50,000$6.59Mput
BMYBRISTOL-MYERS SQUIBB CO130,000$5.86Mshares
NBIXNEUROCRINE BIOSCIENCES INC37,754$5.3Mshares
NKTRNEKTAR THERAPEUTICS75,000$4.27Mshares
HRMYHARMONY BIOSCIENCES HLDGS IN150,000$4.13Mcall
UPBUPSTREAM BIO INC200,000$3.76Mcall
SRRKSCHOLAR ROCK HLDG CORP100,000$3.72Mcall
RAREULTRAGENYX PHARMACEUTICAL IN123,300$3.71Mput
JAZZJAZZ PHARMACEUTICALS PLC23,140$3.05Mshares
COGTCOGENT BIOSCIENCES INC200,000$2.87Mcall
ARCTARCTURUS THERAPEUTICS HLDGS150,900$2.78Mput
MRNAMODERNA INC102,100$2.64Mcall
SCPHARMACEUTICALS INCSCPHARMACEUTICALS INC462,000$2.62Mcall
MRNAMODERNA INC100,000$2.58Mput
REPLREPLIMUNE GROUP INC612,300$2.57Mcall
APGEAPOGEE THERAPEUTICS INC64,250$2.55Mshares
ALKSALKERMES PLC72,079$2.16Mshares
ACADACADIA PHARMACEUTICALS INC89,000$1.9Mcall
ROIVROIVANT SCIENCES LTD120,000$1.82Mshares
MBXMBX BIOSCIENCES INC100,000$1.75Mcall
SMMTSUMMIT THERAPEUTICS INC74,700$1.54Mcall
NVAXNOVAVAX INC173,500$1.5Mcall
NVONOVO-NORDISK A S25,000$1.39Mshares
HRMYHARMONY BIOSCIENCES HLDGS IN50,100$1.38Mput
AMLXAMYLYX PHARMACEUTICALS INC100,000$1.36Mshares
RNAMAVIDITY BIOSCIENCES INC30,000$1.31Mshares
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INC105,891$1.25Mshares
SKYESKYE BIOSCIENCE INC300,000$1.18Mcall
SUPNSUPERNUS PHARMACEUTICALS22,348$1.07Mshares
FOLDAMICUS THERAPEUTIC131,400$1.04Mcall
CPRXCATALYST PHARMACEUTICALS INC50,000$985Kshares
Reviva Pharmaceuticals Hold…Reviva Pharmaceuticals Holdings I…2,506,921$924Kshares
ARCTARCTURUS THERAPEUTICS HLDGS48,811$900Kshares
CTMXCYTOMX THERAPEUTICS INC.185,286$591Kshares
MRNAMODERNA INC20,000$517Kshares
TNYATENAYA THERAPEUTICS INC315,519$511Kshares
ALECALECTOR INC136,023$403Kshares
PYXSPYXIS ONCOLOGY INC150,000$333Kshares
CCCCC4 THERAPEUTICS INC140,700$312Kcall
RAREULTRAGENYX PHARMACEUTICAL IN9,189$276Kshares
CLYMCLIMB BIO INC136,488$274Kshares
OVIDOVID THERAPEUTICS INC187,739$244Kshares
RLAYRELAY THERAPEUTICS INC43,616$228Kshares
RCELAVITA MEDICAL INC25,100$128Kcall
ANABANAPTYSBIO INC3,295$101Kshares
TVRDTVARDI THERAPEUTICS INC2,185$85.1Kshares
MREOMEREO BIOPHARMA GROUP PLC39,400$81.2Kput
KODKODIAK SCIENCES INC1,100$18Kput
PMVPPMV PHARMACEUTICALS INC11,300$15.8Kshares
AUPHAURINIA PHARMACEUTICALS INC700$7.74Kput

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001892688-26-000036 base2026-02-17acceptance time not in the bulk data set